Oroco Resource Corp Upsizes C$20M Bought Deal to Fund Santo Tomás Drilling
Oroco Resource Corp upsized its Canaccord Genuity bought deal to C$20.0 million, issuing 52.63 million units at C$0.38 apiece, each unit comprising one share and half a warrant exercisable at C$0.53 for 36 months. A 15% over-allotment option could add 7.89 million units and C$3.0 million, funding Santo Tomás pre-feasibility drilling and permitting.
1. Bought Deal Increased to C$20.0 Million
Oroco Resource Corp. has amended its agreement with Canaccord Genuity, as lead underwriter and sole bookrunner for a syndicate of underwriters, to ups ize its bought deal financing from C$15.0 million to aggregate gross proceeds of approximately C$20.0 million. The amended Offering will consist of 52,631,600 units at C$0.38 each, reflecting strong institutional demand and oversubscription relative to the initial syndicate commitments.
2. Unit Composition and Over-Allotment Option
Each unit comprises one common share and one-half of one common share purchase warrant, with each whole warrant exercisable at C$0.53 for 36 months post-closing. The Underwriters hold a 30-day over-allotment option to acquire up to 7,894,740 additional units (15% of the base offering) on identical terms, potentially adding approximately C$3.0 million in gross proceeds and bringing total potential financing to C$23.0 million.
3. Use of Proceeds and Strategic Priorities
Net proceeds will fund Pre-Feasibility Study drilling at the Santo Tomás copper project, advance baseline environmental and permitting work, and support general corporate working capital. The project area covers 9,034 hectares in northwestern Mexico, including 1,173 hectares of core concessions (85.5% ownership) and 7,861 hectares of surrounding concessions (80% ownership).
4. Expected Closing and Regulatory Approvals
The Offering is set to close on or about January 14, 2026, subject to customary conditions and TSX Venture Exchange approval. The units will be issued under a prospectus supplement to the company’s April 23, 2025, base shelf prospectus and may be sold to qualified U.S. institutional and accredited investors under Rule 144A and Rule 506(b).